What is the optimal blood pressure management for a patient taking hydrochlorothiazide 25 mg who has hyperuricemia (uric acid 9 mg/dL)?

Switch from Hydrochlorothiazide to Alternative Antihypertensive

For a patient on hydrochlorothiazide 25 mg with a uric acid level of 9 mg/dL, you should switch to an alternative antihypertensive regimen, preferably using losartan or a calcium channel blocker, as thiazide diuretics are directly causing the hyperuricemia and increasing gout risk.

Why Hydrochlorothiazide Must Be Changed

The 2017 ACC/AHA guidelines explicitly state to "use with caution in patients with history of acute gout unless patient is on uric acid–lowering therapy" 1, 2, 1. Your patient has severe hyperuricemia (9 mg/dL) which substantially exceeds normal thresholds and puts them at high risk for gout attacks.

The FDA label confirms that hydrochlorothiazide "decreases the excretion of calcium and uric acid" as a direct pharmacologic effect 3. This is not a rare side effect—it's the expected mechanism. Clinical data shows:

• 24.5% of thiazide users develop hyperuricemia versus 15.3% of non-users 4
• Thiazide users have significantly higher mean uric acid levels (5.9 vs 5.3 mg/dL) 4
• Risk of requiring anti-gout therapy increases 2-fold with thiazide use (RR 1.99-2.29) 5
• The risk is dose-dependent, with doses ≥25 mg/day showing significantly increased gout treatment initiation 5

Your patient is on exactly the dose (25 mg) where gout risk becomes clinically significant.

Recommended Antihypertensive Switch

First Choice: Losartan-Based Regimen

Switch to losartan 50-100 mg daily as your primary antihypertensive 1, 2, 1, 6. The 2020 ACR Gout Guidelines specifically recommend "choosing losartan preferentially as an antihypertensive agent when feasible" for patients with gout 7.

Losartan uniquely lowers uric acid through uricosuric effects:

• Losartan combined with amlodipine reduced uric acid from 6.5 to 4.6 mg/dL (p=0.0001) 8
• Switching from other ARBs to losartan/HCTZ decreased uric acid by 0.44 mg/dL despite continued diuretic use 9
• Losartan is the only ARB with significant urate-lowering properties 10

Second Choice: Calcium Channel Blocker

If losartan is contraindicated, use amlodipine 5-10 mg daily 1, 2, 1. CCBs are metabolically neutral and don't affect uric acid levels. The combination of losartan plus amlodipine provides excellent BP control while actively lowering uric acid 8.

What NOT to Do

• Do not continue hydrochlorothiazide at any dose with uric acid of 9 mg/dL
• Do not switch to chlorthalidone or indapamide—these are also thiazide-type diuretics with the same uric acid elevation problem 1, 2
• Do not add allopurinol while continuing HCTZ—this treats the symptom while perpetuating the cause

Managing the Hyperuricemia

With uric acid at 9 mg/dL, your patient needs urate-lowering therapy regardless of whether they've had gout symptoms:

The 2025 KDOQI guidelines recommend initiating uric acid-lowering therapy "after the first episode of gout, particularly where serum uric acid concentration is >9 mg/dL" 11. The 2020 ACR guidelines support starting urate-lowering therapy for patients with recurrent gout (>2 attacks/year) 7.

Start allopurinol 100 mg daily and titrate up by 100 mg increments every 2-4 weeks to achieve target uric acid <6 mg/dL 12, 11, 7. The "go low, go slow" approach reduces acute gout flare risk during initiation 13.

Provide colchicine 0.6 mg daily as prophylaxis during the first 3-6 months of urate-lowering therapy to prevent flares 12, 11, 7.

Clinical Algorithm

1. Immediately: Switch HCTZ 25 mg to losartan 50 mg daily (or amlodipine 5 mg if losartan contraindicated)
2. Week 1: Check BP, renal function, potassium
3. Week 2-4: Titrate losartan to 100 mg if BP not at goal
4. Simultaneously: Start allopurinol 100 mg + colchicine 0.6 mg daily for gout prophylaxis
5. Monthly: Titrate allopurinol by 100 mg increments until uric acid <6 mg/dL
6. 3-6 months: Continue colchicine prophylaxis, then reassess

Important Caveats

• Monitor potassium and creatinine when starting losartan, especially if patient has CKD 1
• If patient requires a diuretic for volume overload (not just hypertension), use a loop diuretic instead of thiazides 1, 14
• The 2017 ACC/AHA guidelines note that gout occurrence is "uncommon with dosages ≤50 mg/d of hydrochlorothiazide" 15, but your patient has already developed severe hyperuricemia, making this threshold irrelevant
• Asymptomatic hyperuricemia alone doesn't mandate treatment 12, but uric acid of 9 mg/dL with ongoing thiazide exposure requires intervention to prevent gout and potential cardiovascular complications 16